Emerging Trends: Luminescence Detection of Cytokines

1. New progress in luminescence:

The number of manufacturers is gradually increasing

The addition of new brands is bound to accelerate the clinical acceptance of luminescence detection cytokines.

Differentiation began to emerge in the items

From the perspective of the manufacturers that have been certified so far, the main items cover IL-1β, IL-2, IL-2R, IL-4, IL-5, IL-6, IL-8, IL-10, TNF-α, IL-17, IFN-α, IFN-γ, etc.

2. How to promote the market？

Clinical clarity is required

As a manufacturer, the product line can be invested in more academic activities with sufficient funds, increase academic influence, and expand brand awareness;

If the funds are not rich enough, you can use the medical manager to increase the pre-sales publicity, and every clinical exchange is actually to tell the insiders the value of the project. 

The promotional content focuses on which departments can be opened, what are the items that need to be focused on by different diseases/departments, and what the high or low indicators represent.

In the end, it will stand the test of time

Evaluate that you have to get by and maintain customer stickiness in order to go long-term.